Report Description Table of Contents Urology Robotic Surgery Market: How Are Rising Procedure Volumes and New Platforms Expanding Surgical Revenue? – (Updated On: 6th-Nov-2026) According to Strategic Market Research, the Global Urology Robotic Surgery Market was valued at USD 2.55 billion in 2025 and is projected to reach USD 5.35 billion by 2032, expanding at a CAGR of 11.2% during 2026–2032. Increasing robotic-assisted urological procedures, new surgical platform approvals, and expanding clinical applications are supporting market growth. Robotic-assisted surgery has become the dominant approach for radical prostatectomy in the United States. According to the American Urological Association's AQUA Registry, robotic-assisted procedures accounted for 94.8% of recorded radical prostatectomies in 2021, increasing from 83% in 2014. This demonstrates the established clinical adoption of robotic surgery in prostate cancer treatment. Increasing robotic urology procedure volumes are strengthening market demand. According to Intuitive Surgical's 2025 annual filing, approximately 708,000 urological procedures were performed worldwide using da Vinci systems in 2025, compared with 621,000 in 2024. The United States accounted for approximately 201,000 procedures, representing 8% annual growth, while procedures outside the United States reached 507,000, increasing 16%. These figures indicate expanding international adoption and recurring demand for robotic surgical instruments and accessories. New FDA clearances are strengthening competition in robotic urological surgery. On December 3, 2025, Medtronic received FDA clearance for its Hugo robotic-assisted surgery system, covering minimally invasive prostatectomy, nephrectomy, and cystectomy procedures. The clearance followed the multicenter Expand URO clinical study, which met its primary safety and effectiveness endpoints. Medtronic reported that these procedures collectively represent approximately 230,000 surgeries annually in the United States, highlighting the commercial opportunity for additional robotic surgical platforms. Single-port robotic systems are expanding specialized urological applications. Intuitive Surgical's da Vinci SP system received FDA clearance in May 2018 for urological procedures. The platform supports specialized minimally invasive approaches, particularly in prostate surgery, while ongoing clinical development is extending its use across selected urological procedures. Robotic-assisted kidney surgery is contributing to international procedure growth. Intuitive Surgical identified partial nephrectomy as an important contributor to international urology procedure growth in 2025. Increasing adoption of robotic-assisted kidney surgery is creating additional opportunities beyond the established prostatectomy segment. The Global Urology Robotic Surgery Market is projected to generate approximately USD 2.80 billion in additional annual revenue by 2032, supported by increasing surgical volumes, expanding clinical applications, and new regulatory clearances. Intuitive Surgical and Medtronic remain key competitors, with differentiated surgical platforms and growing international adoption shaping market opportunities. Which Surgical Procedures, Robotic Platforms, Applications, and Regional Markets Are Shaping Urology Robotic Surgery? By Surgical Procedure: Established Prostatectomy Programs and Kidney Preservation Shape Adoption Largest Subsegment – Robotic-Assisted Radical Prostatectomy Robotic-assisted radical prostatectomy leads the surgical procedure segment of the Urology Robotic Surgery Market, accounting for an estimated 52% market share and USD 1.326 billion in 2025, with a projected CAGR of 10.3% during 2026–2032. Robot-assisted radical prostatectomy (RARP) has emerged as a preferred surgical approach for localized prostate cancer, increasingly replacing conventional open and laparoscopic procedures. Its growing adoption across specialized urology centers, supported by favorable surgical outcomes and expanding access to robotic surgery platforms, reinforces its leading market position. Fastest-Growing Subsegment – Robotic-Assisted Partial Nephrectomy Robotic-assisted partial nephrectomy (RAPN) represents a significant procedure category within the Urology Robotic Surgery Market, accounting for an estimated 30% market share, valued at USD 0.765 billion in 2025, and recording the fastest projected CAGR of 13.6% during 2026–2032. RAPN enables surgeons to remove localized kidney tumors while preserving healthy renal tissue, supporting kidney function and reducing surgical complications. Growing clinical preference for kidney-sparing procedures, particularly among patients with small renal masses, is strengthening the adoption of robotic-assisted partial nephrectomy across specialized urology centers. By Product Type: Platform Investment and Recurring Instrument Use Shape Revenue Largest Subsegment – Robotic Surgical Systems Robotic surgical systems lead the Urology Robotic Surgery Market with an estimated 43% market share, valued at USD 1.097 billion in 2025, and are projected to grow at a CAGR of 9.2% during 2026–2032. Robotic surgical systems operate as precision-guided instruments controlled entirely by urologists from a surgical console rather than functioning autonomously. Their growing use in prostatectomy, partial nephrectomy, and other complex urological procedures reinforces their market leadership, supported by greater surgical precision, improved procedural control, and expanding adoption across specialized urology centers. Fastest-Growing Subsegment – Instruments & Accessories Instruments and accessories accounted for an estimated 39% share of the Urology Robotic Surgery Market, valued at USD 0.995 billion in 2025, and are projected to register the fastest CAGR of 13.7% during 2026–2032. Robotic instruments and accessories play a critical role in translating surgeons’ movements into precise actions during urologic procedures, including prostatectomy, partial nephrectomy, and reconstructive surgeries. Increasing robotic-assisted urological procedures, wider hospital adoption, and recurring replacement of surgical instruments are supporting sustained market expansion and commercial opportunities for established manufacturers. By Robotic System Type: Multi-Port Experience Meets Single-Incision Innovation Largest Subsegment – Multi-Port Robotic Systems Multi-port robotic systems dominated the Urology Robotic Surgery Market, accounting for an estimated 76% market share and USD 1.938 billion in 2025, with a projected CAGR of 10.0% during 2026–2032. Established platforms such as Intuitive Surgical’s da Vinci Surgical System have strengthened multi-port adoption across prostatectomy, partial nephrectomy, and other urological procedures. Their established presence in hospitals, extensive surgeon experience, and widespread use in complex urological surgeries continue to support market leadership and sustained commercial expansion. Fastest-Growing Subsegment – Single-Port Robotic Systems Single-port robotic systems accounted for an estimated 17% share of the Urology Robotic Surgery Market, valued at USD 0.434 billion in 2025, and are projected to record the fastest CAGR of 17.5% during 2026–2032. Growth is supported by increasing adoption of single-incision robotic procedures in urology, particularly for prostate and kidney surgeries. Intuitive Surgical’s da Vinci SP platform supports complex urological procedures through a single surgical entry point, expanding minimally invasive treatment options and strengthening the commercial outlook for single-port robotic surgery systems. By Application: Prostate Cancer Programs and Kidney-Sparing Surgery Expand Demand Largest Subsegment – Prostate Cancer Surgery Prostate cancer surgery leads the Urology Robotic Surgery Market, accounting for an estimated 54% market share, valued at USD 1.377 billion in 2025, with a projected CAGR of 10.2% during 2026–2032. Robot-assisted radical prostatectomy (RARP) has become a leading surgical approach for localized prostate cancer, supported by its widespread adoption across modern urology practices. Increasing preference for minimally invasive prostate cancer procedures and expanding availability of robotic surgical platforms across specialized hospitals are strengthening its position in urological surgery. Fastest-Growing Subsegment – Kidney Cancer Surgery Kidney cancer surgery accounted for an estimated 29% share of the Urology Robotic Surgery Market, valued at USD 0.740 billion in 2025, and is projected to register the fastest CAGR of 13.7% during 2026–2032. Growth is supported by increasing adoption of robotic-assisted partial nephrectomy, which enables precise tumor removal while preserving healthy kidney tissue. The growing preference for minimally invasive kidney cancer procedures, improved surgical outcomes, and wider use of kidney-preserving treatment approaches are strengthening robotic surgery adoption across specialized urology centers. By End User: Hospital Infrastructure and Outpatient Expansion Shape Purchasing Largest Subsegment – Hospitals Hospitals dominate the Urology Robotic Surgery Market, accounting for an estimated 82% market share, valued at USD 2.091 billion in 2025, with a projected CAGR of 10.7% during 2026–2032. Their leadership is supported by established surgical infrastructure, access to advanced robotic surgery platforms, and specialized urology teams performing complex procedures. The growing adoption of robotic-assisted prostatectomy, partial nephrectomy, and other urological surgeries across major hospitals further strengthens their position as leading centers for robotic urological procedures worldwide. Fastest-Growing Subsegment – Ambulatory Surgical Centers Ambulatory Surgical Centers (ASCs) accounted for an estimated 6% share of the Urology Robotic Surgery Market, valued at USD 0.153 billion in 2025, and are projected to register the fastest CAGR of 14.2% during 2026–2032. Growth is supported by the increasing adoption of robotic-assisted urological procedures in outpatient settings, allowing eligible patients to undergo same-day surgery while reducing hospitalization costs. The expansion of robotic prostatectomy and other minimally invasive urological procedures into ASCs is strengthening their commercial potential through improved cost efficiency and favorable patient outcomes. By Geography: North American Surgical Capacity and Asian Adoption Expand Revenue Largest Regional Segment – North America North America holds a leading position in the Urology Robotic Surgery Market, accounting for approximately 42% of the global market, valued at USD 1.071 billion in 2025, and is projected to grow at a CAGR of 9.6% during 2026–2032. Urology has played a pioneering role in advancing robotic-assisted surgery across North America, particularly in prostatectomy and kidney procedures. The region's established robotic surgery infrastructure, experienced urologic surgeons, and increasing adoption across major healthcare institutions continue to support market expansion. Fastest-Growing Regional Segment – Asia-Pacific The Asia-Pacific Urology Robotic Surgery Market is witnessing increasing clinical adoption, with robotic-assisted procedures becoming more established across complex urological interventions, particularly prostatectomy, partial nephrectomy, and reconstructive surgeries. The region accounted for an estimated 24% of the global market, valued at USD 0.612 billion in 2025, and is projected to register the fastest regional CAGR of 14.5% during 2026–2032. Expanding robotic surgery programs, growing surgeon expertise, and increasing access to advanced urological care across China, Japan, India, and South Korea support regional market expansion. Which Companies Are Leading the Competitive Landscape of Urology Robotic Surgery? Intuitive Surgical – Established Leader in Robotic Urological Surgery Intuitive Surgical maintains a leading position through its da Vinci robotic surgery portfolio and extensive use in robotic-assisted prostatectomy and partial nephrectomy. According to its 2025 annual report, approximately 708,000 da Vinci urology procedures were performed worldwide in 2025, including 201,000 in the United States and 507,000 internationally. International urology procedure volumes increased approximately 16% year over year. The company also reported 11,106 da Vinci surgical systems worldwide at year-end 2025 and USD 6.02 billion in instruments and accessories revenue across its surgical portfolio. These figures demonstrate its significant clinical presence and recurring revenue opportunities, particularly in prostate and kidney surgery. Medtronic – Expanding Competition Through Hugo Robotic-Assisted Surgery Medtronic is strengthening its position through the Hugo robotic-assisted surgery system, providing an alternative platform for robotic prostatectomy, nephrectomy, and cystectomy. On December 3, 2025, the company announced U.S. FDA clearance for these urological indications, covering procedure categories that Medtronic estimates collectively account for approximately 230,000 surgeries annually in the United States. The company also reported that Hugo had been used in tens of thousands of procedures across multiple specialties in more than 30 countries outside the United States. This regulatory milestone creates opportunities for Medtronic to compete in the established U.S. robotic urology market and expand its international hospital presence. CMR Surgical – Emerging Global Competitor Through Versius CMR Surgical is expanding its international presence through the Versius robotic surgery platform, including applications in urology and other soft-tissue procedures. In March 2026, the company announced that its Versius platform had been used to treat more than 45,000 patients worldwide, compared with over 30,000 procedures reported in April 2025. CMR also secured more than USD 200 million in financing in April 2025, supporting international commercialization. Its strategic alliance with Stryker, announced in October 2026, establishes Stryker as the exclusive U.S. sales agent for the Versius portfolio. These developments strengthen CMR's commercial reach, although reported procedure totals cover multiple specialties rather than urology alone. Other Companies and Their Market Roles: MicroPort MedBot: Chinese robotic surgery manufacturer expanding its Toumai platform in prostate cancer surgery, including a documented remote radical prostatectomy conducted in Belgium in May 2025. Distalmotion: Swiss manufacturer of the DEXTER robotic surgery system, with European experience in urological procedures and a growing commercial focus on outpatient robotic surgery; it secured USD 150 million in financing in November 2025. Analyst Commentary: How Will Affordability and Surgical Utilization Shape Competitive Returns? The Urology Robotic Surgery Market offers significant opportunities for manufacturers that can expand robotic surgery access beyond established hospital networks while improving system affordability and surgical utilization. Recurring instrument revenues, growing adoption of kidney-preserving procedures, and increasing competition among robotic platform providers are expected to influence profitability and market positioning. Companies combining competitive pricing with strong clinical adoption and international expansion are likely to capture greater commercial opportunities. Urology Robotic Surgery Market Report Coverage Table Report Attribute Details Forecast Period 2026 – 2032 Market Size Value in 2025 USD 2.55 Billion Revenue Forecast in 2032 USD 5.35 Billion Overall Growth Rate CAGR of 11.2% (2026 – 2032) Base Year for Estimation 2025 Historical Data 2019 – 2024 Unit USD Million/Billion, CAGR (2026 – 2032) Segmentation By Surgical Procedure, By Product Type, By Robotic System Type, By Application, By End User, By Geography By Surgical Procedure Robotic-Assisted Radical Prostatectomy, Robotic-Assisted Partial Nephrectomy, Robotic-Assisted Radical Cystectomy By Product Type Robotic Surgical Systems, Instruments & Accessories, Services & Maintenance By Robotic System Type Multi-Port Robotic Systems, Single-Port Robotic Systems, Hybrid Robotic Surgical Systems By Application Prostate Cancer Surgery, Kidney Cancer Surgery, Bladder Cancer Surgery By End User Hospitals, Ambulatory Surgical Centers, Specialty Urology Clinics By Region North America, Europe, Asia-Pacific, Latin America, Middle East & Africa Country Scope U.S., Canada, UK, Germany, France, Italy, China, Japan, South Korea, India, Brazil, Mexico, Saudi Arabia, UAE, South Africa Market Drivers Increasing robotic urology procedure volumes, expanding international adoption, entry of additional surgical platforms, development of single-port applications, recurring demand for instruments, accessories, and maintenance Customization Option Available upon request Frequently Asked Question About This Report Q1. What factors are driving growth across the market? A1. Growth is supported by increasing robotic-assisted prostatectomy, partial nephrectomy, and cystectomy procedures, along with new robotic platform approvals and expanding hospital investment in robotic surgery infrastructure. Q2. What are the key technology trends shaping the industry? A2. The industry is moving toward single-port robotic systems, advanced multi-port platforms, precision surgical instruments, and new robotic platforms that expand minimally invasive urological procedures. Q3. Which surgical procedure offers the strongest growth opportunity in the market? A3. Robotic-assisted partial nephrectomy is projected to record the fastest procedure CAGR of 13.6% during 2026–2032. Growing preference for kidney-preserving surgery in patients with localized renal tumors is supporting adoption. Q4. Why are single-port robotic systems gaining importance in the industry? A4. Single-port systems enable selected urological procedures through a single surgical entry point. Their market is projected to grow at a CAGR of 17.5% during 2026–2032, supported by increasing interest in less invasive robotic procedures. Q5. Which end-user segment is expected to expand the fastest? A5. Ambulatory Surgical Centers are projected to record the fastest end-user CAGR of 14.2% during 2026–2032. Growth is supported by the gradual movement of selected robotic urological procedures into outpatient settings. Q6. Which region is expected to record the fastest growth in the industry? A6. Asia-Pacific is projected to record the fastest regional CAGR of 14.5% during 2026–2032. Growth is supported by expanding robotic surgery programs, increasing surgeon expertise, and improving access to advanced urological care across China, Japan, India, and South Korea. Sources: Intuitive Surgical – Approximately 708,000 da Vinci Urology Procedures Worldwide in 2025, Compared With 621,000 in 2024 Intuitive Surgical – 2025 Form 10-K: Urology Procedure Volumes and Regional Growth U.S. FDA – Medtronic Hugo Robotic-Assisted Surgery System Received 510(k) Clearance on December 3, 2025, Under K250725 FDA – Hugo RAS System: 510(k) Premarket Notification K250725 Medtronic – Hugo’s Cleared Urologic Procedure Categories Represent Approximately 230,000 U.S. Surgeries Annually Medtronic – FDA Clearance of Hugo for Urologic Surgical Procedures, December 2025 Medtronic – Expand URO Study Reported 98.5% Surgical Success Across 137 Patients at Six U.S. Hospitals Medtronic – Expand URO Clinical Study: Safety and Effectiveness Results for Hugo MicroPort – Toumai Enabled a Remote Robotic Radical Prostatectomy in Belgium on May 26, 2025, With Reported Bidirectional Latency of 20 Milliseconds MicroPort – Toumai Robotic Telesurgery Development, June 2025 U.S. FDA – da Vinci SP Surgical System Received Its Historical 510(k) Clearance on May 31, 2018, Under K173906 FDA – da Vinci SP Surgical System, EndoWrist SP Instruments, and Accessories: K173906 CMR Surgical – More Than 45,000 Patients Treated Worldwide Using Versius, Announced March 26, 2026 CMR Surgical – Versius Reaches More Than 45,000 Patients Globally Distalmotion – Closed a USD 150 Million Series G Financing Round on November 18, 2025 Distalmotion – USD 150 Million Financing to Accelerate DEXTER Expansion Table of Contents - Global Urology Robotic Surgery Market Report (2026–2032) Executive Summary Market Overview Market Attractiveness by Surgical Procedure, Product Type, Robotic System Type, Application, End User, and Region Strategic Insights from Key Executives (CXO Perspective) Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Summary of Market Segmentation by Surgical Procedure, Product Type, Robotic System Type, Application, End User, and Region Market Share Analysis Leading Players by Revenue and Market Share Market Share Analysis by Surgical Procedure, Product Type, Robotic System Type, Application, and End User Investment Opportunities in the Urology Robotic Surgery Market Key Developments and Innovations Mergers, Acquisitions, and Strategic Partnerships High-Growth Segments for Investment Opportunities in Robotic-Assisted Radical Prostatectomy, Partial Nephrectomy, Radical Cystectomy, Single-Port Robotic Systems, Surgical Instruments and Accessories, and Robotic Platform Expansion Market Introduction Definition and Scope of the Study Market Structure and Key Findings Overview of Top Investment Pockets Strategic Importance of Robotic-Assisted Urological Surgery in Prostate Cancer, Kidney Cancer, and Bladder Cancer Management Role of Robotic Platforms in Minimally Invasive Urological Procedures Research Methodology Research Process Overview Primary and Secondary Research Approaches Market Size Estimation and Forecasting Techniques Data Triangulation and Segment-Level Forecasting Approach Market Dynamics Key Market Drivers Challenges and Restraints Impacting Growth Emerging Opportunities for Stakeholders Impact of Regulatory Clearances and Clinical Adoption Role of Increasing Robotic-Assisted Urology Procedure Volumes in Market Expansion Impact of New Robotic Platform Approvals and Expanding Clinical Applications Recurring Demand for Robotic Surgical Instruments, Accessories, and Maintenance Single-Port Robotic Surgery Adoption and Kidney-Preserving Surgical Approaches Global Urology Robotic Surgery Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Surgical Procedure: Robotic-Assisted Radical Prostatectomy Robotic-Assisted Partial Nephrectomy Robotic-Assisted Radical Cystectomy Market Analysis by Product Type: Robotic Surgical Systems Instruments & Accessories Services & Maintenance Market Analysis by Robotic System Type: Multi-Port Robotic Systems Single-Port Robotic Systems Hybrid Robotic Surgical Systems Market Analysis by Application: Prostate Cancer Surgery Kidney Cancer Surgery Bladder Cancer Surgery Market Analysis by End User: Hospitals Ambulatory Surgical Centers Specialty Urology Clinics Market Analysis by Region: North America Europe Asia-Pacific Latin America Middle East & Africa Regional Market Analysis North America Urology Robotic Surgery Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Surgical Procedure, Product Type, Robotic System Type, Application, and End User Country-Level Breakdown: United States Canada Mexico Europe Urology Robotic Surgery Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Surgical Procedure, Product Type, Robotic System Type, Application, and End User Country-Level Breakdown: Germany United Kingdom France Italy Spain Rest of Europe Asia-Pacific Urology Robotic Surgery Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Surgical Procedure, Product Type, Robotic System Type, Application, and End User Country-Level Breakdown: China India Japan South Korea Australia Rest of Asia-Pacific Latin America Urology Robotic Surgery Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Surgical Procedure, Product Type, Robotic System Type, Application, and End User Country-Level Breakdown: Brazil Mexico Rest of Latin America Middle East & Africa Urology Robotic Surgery Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Surgical Procedure, Product Type, Robotic System Type, Application, and End User Country-Level Breakdown: Saudi Arabia United Arab Emirates South Africa Rest of Middle East & Africa Competitive Intelligence and Benchmarking Leading Key Players: Intuitive Surgical, Inc. Medtronic plc CMR Surgical MicroPort MedBot Distalmotion Stryker Corporation Johnson & Johnson Asensus Surgical Smith+Nephew Competitive Landscape and Strategic Insights Benchmarking Based on Robotic Platform Portfolios, Clinical Applications, Regulatory Clearances, Procedure Volumes, and Regional Presence Robotic Surgical System Portfolio Positioning Multi-Port and Single-Port Robotic Platform Comparison Robotic Instruments, Accessories, and Services Competitive Analysis FDA Clearance and International Regulatory Expansion Strategies Strategic Developments and Platform Adoption During 2025–2026 Appendix Abbreviations and Terminologies Used in the Report References and Sources Historical Data Coverage (2019–2024) Base Year Definitions and Assumptions (2025) Forecast Methodology and Assumptions (2026–2032) List of Tables Market Size by Surgical Procedure, Product Type, Robotic System Type, Application, End User, and Region (2026–2032) Regional Market Breakdown by Segment Type (2026–2032) Country-Level Market Analysis Across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa Competitive Benchmarking of Leading Robotic Surgery Platform Providers Robotic-Assisted Urological Procedure Trends and Platform Adoption Regulatory Clearances and Robotic Platform Developments During 2025–2026 Robotic Surgical Systems, Instruments, Accessories, and Maintenance Analysis List of Figures Market Drivers, Challenges, Opportunities, and Restraints Regional Market Snapshot Competitive Landscape by Market Share Growth Strategies Adopted by Key Players Market Share by Surgical Procedure, Product Type, Robotic System Type, Application, and End User (2025 vs. 2032) Global Urology Robotic Surgery Ecosystem and Value Chain Analysis Robotic-Assisted Urology Procedure Adoption Trends (2019–2025) Robotic Surgery Platform Expansion and Clinical Application Trends (2025–2032)